EverCommerce (EVCM) 10-Q 10 Nov 22 2022 Q3 Quarterly report Financial data

Cover Page

Cover Page - shares	9 Months Ended
	Sep. 30, 2022	Nov. 04, 2022
Cover [Abstract]
Document Type	10-Q
Document Quarterly Report	true
Document Period End Date	Sep. 30, 2022
Document Transition Report	false
Entity File Number	001-40575
Entity Registrant Name	EverCommerce Inc.
Entity Incorporation, State or Country Code	DE
Entity Tax Identification Number	81-4063248
Entity Address, Address Line One	3601 Walnut Street, Suite 400
Entity Address, City or Town	Denver
Entity Address, State or Province	CO
Entity Address, Postal Zip Code	80205
City Area Code	720
Local Phone Number	647-4948
Title of 12(b) Security	Common stock, $0.00001 par value
Trading Symbol	EVCM
Security Exchange Name	NASDAQ
Entity Current Reporting Status	Yes
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	false
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	false
Entity Common Stock, Shares Outstanding		193,201,157
Entity Central Index Key	0001853145
Amendment Flag	false
Current Fiscal Year End Date	--12-31
Document Fiscal Year Focus	2022
Document Fiscal Period Focus	Q3

Condensed Consolidated Balance

Condensed Consolidated Balance Sheets (unaudited) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Current assets:
Cash and cash equivalents	$ 91,473	$ 93,993
Restricted cash	3,748	3,566
Accounts receivable, net of allowance for doubtful accounts of $3.2 million and $1.9 million at September 30, 2022 and December 31, 2021, respectively	49,762	40,514
Contract assets	13,782	11,039
Prepaid expenses and other current assets	26,319	22,505
Total current assets	185,084	171,617
Non-current assets:
Property and equipment, net	12,507	13,509
Capitalized software, net	31,100	24,000
Other non-current assets	21,688	24,296
Intangible assets, net	430,233	508,535
Goodwill	907,243	921,416
Total non-current assets	1,402,771	1,491,756
Total assets	1,587,855	1,663,373
Current liabilities:
Accounts payable	8,740	10,325
Accrued expenses and other	47,387	49,340
Deferred revenue	25,300	22,992
Customer deposits	10,176	9,828
Current maturities of long-term debt	8,282	10,943
Total current liabilities	99,885	103,428
Non-current liabilities:
Deferred tax liability, net	6,700	17,862
Long-term deferred revenue	2,596	2,803
Long-term debt, net of current maturities and deferred financing costs	532,006	535,184
Other non-current liabilities	17,532	18,448
Total non-current liabilities	558,834	574,297
Total liabilities	658,719	677,725
Commitments and contingencies (Note 15)
Stockholders’ equity:
Preferred stock, $0.00001 par value, 50,000,000 shares authorized and no shares issued or outstanding as of September 30, 2022 and December 31, 2021	0	0
Common stock, $0.00001 par value, 2,000,000,000 shares authorized and 193,937,954 and 195,384,291 shares issued and outstanding at September 30, 2022 and December 31, 2021, respectively	2	2
Accumulated other comprehensive loss	(17,578)	(1,767)
Additional paid-in capital	1,501,985	1,500,643
Accumulated deficit	(555,273)	(513,230)
Total stockholders’ equity	929,136	985,648
Total liabilities, convertible preferred stock and stockholders’ equity	$ 1,587,855	$ 1,663,373

Condensed Consolidated Balanc_2

Condensed Consolidated Balance Sheets (unaudited) (Parenthetical) - USD ($) $ in Millions	Sep. 30, 2022	Dec. 31, 2021
Statement of Financial Position [Abstract]
Allowance for doubtful accounts	$ 3.2	$ 1.9
Preferred stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Preferred stock, shares authorized (in shares)	50,000,000	50,000,000
Preferred stock, shares issued (in shares)	0	0
Preferred stock shares outstanding (in shares)	0	0
Common stock, par value (in dollars per share)	$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)	2,000,000,000	2,000,000,000
Common stock, shares issued (in shares)	193,937,954	195,384,291
Common stock, shares outstanding (in shares)	193,937,954	195,384,291

Condensed Consolidated Statemen

Condensed Consolidated Statements of Operations and Comprehensive Loss (unaudited) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Revenues:
Total revenues	$ 158,126	$ 128,534	$ 458,948	$ 354,490
Operating expenses:
Cost of revenues (exclusive of depreciation and amortization presented separately below)	57,655	42,958	163,503	119,488
Sales and marketing	29,440	25,156	89,531	67,647
Product development	18,508	12,711	53,568	35,083
General and administrative	32,164	25,779	96,748	79,796
Depreciation and amortization	27,613	25,996	82,524	73,917
Total operating expenses	165,380	132,600	485,874	375,931
Operating loss	(7,254)	(4,066)	(26,926)	(21,441)
Interest and other expense, net	(8,890)	(5,148)	(21,070)	(31,262)
Loss on debt extinguishment	0	(28,714)	0	(28,714)
Net loss before income tax benefit	(16,144)	(37,928)	(47,996)	(81,417)
Income tax benefit	291	1,022	5,953	4,182
Net loss	(15,853)	(36,906)	(42,043)	(77,235)
Other comprehensive loss:
Foreign currency translation losses, net	(6,978)	(3,430)	(15,811)	(2,518)
Comprehensive loss	(22,831)	(40,336)	(57,854)	(79,753)
Net loss attributable to common stockholders:
Net loss	(15,853)	(36,906)	(42,043)	(77,235)
Adjustments to net loss (see Note 12)	0	0	0	(15,105)
Net loss attributable to common stockholders, basic	(15,853)	(36,906)	(42,043)	(92,340)
Net loss attributable to common stockholders, diluted	$ (15,853)	$ (36,906)	$ (42,043)	$ (92,340)
Basic net loss per share attributable to common stockholders (in dollars per share)	$ (0.08)	$ (0.20)	$ (0.22)	$ (1.01)
Diluted net loss per share attributable to common stockholders (in dollars per share)	$ (0.08)	$ (0.20)	$ (0.22)	$ (1.01)
Basic weighted-average shares of common stock outstanding used in computing net loss per share (in shares)	194,542,764	187,994,437	195,205,260	91,655,461
Diluted weighted-average shares of common stock outstanding used in computing net loss per share (in shares)	194,542,764	187,994,437	195,205,260	91,655,461
Subscription and transaction fees
Revenues:
Total revenues	$ 120,085	$ 91,788	$ 343,734	$ 252,119
Marketing technology solutions
Revenues:
Total revenues	36,276	31,610	101,340	88,974
Other
Revenues:
Total revenues	$ 1,765	$ 5,136	$ 13,874	$ 13,397

Condensed Consolidated Statem_2

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) (unaudited) - USD ($) $ in Thousands	Total	Preferred Stock	Common Stock	Additional Paid-In Capital	Accumulated Deficit	Accumulated Other Comprehensive Loss	Series B Convertible Preferred Stock	Series C Convertible Preferred Stock	Series A Convertible Preferred Stock
Beginning balance (in shares) at Dec. 31, 2020							72,226,000	0	44,958,000
Beginning balance at Dec. 31, 2020	$ 908,310						$ 745,046	$ 0	$ 163,264
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Series B convertible preferred stock to redemption value	15,105						$ 15,105
Ending balance (in shares) at Mar. 31, 2021							72,226,000	0	44,958,000
Ending balance at Mar. 31, 2021	923,415						$ 760,151	$ 0	$ 163,264
Beginning balance (in shares) at Dec. 31, 2020			43,074,000
Beginning balance at Dec. 31, 2020	(389,154)		$ 0	$ 40,564	$ (431,264)	$ 1,546
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Rollover equity in consideration of net assets acquired (in shares)			45,000
Rollover equity in consideration of net assets acquired	416			416
Stock-based compensation	903			903
Stock option exercises (in shares)			223,000
Stock option exercises	735			735
Foreign currency translation losses, net	543					543
Accretion of Series B convertible preferred stock to redemption value	(15,105)			(15,105)
Net loss	(15,995)				(15,995)
Ending balance (in shares) at Mar. 31, 2021			43,342,000
Ending balance at Mar. 31, 2021	(417,657)		$ 0	27,513	(447,259)	2,089
Beginning balance (in shares) at Dec. 31, 2020							72,226,000	0	44,958,000
Beginning balance at Dec. 31, 2020	908,310						$ 745,046	$ 0	$ 163,264
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Series B convertible preferred stock to redemption value	15,105
Ending balance (in shares) at Sep. 30, 2021							0	0	0
Ending balance at Sep. 30, 2021	0						$ 0	$ 0	$ 0
Beginning balance (in shares) at Dec. 31, 2020			43,074,000
Beginning balance at Dec. 31, 2020	(389,154)		$ 0	40,564	(431,264)	1,546
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Rollover equity in consideration of net assets acquired	726
Foreign currency translation losses, net	(2,518)
Accretion of Series B convertible preferred stock to redemption value							$ (15,100)
Net loss	(77,235)
Ending balance (in shares) at Sep. 30, 2021			195,356,000
Ending balance at Sep. 30, 2021	983,797		$ 2	1,493,266	(508,499)	(972)
Beginning balance (in shares) at Mar. 31, 2021							72,226,000	0	44,958,000
Beginning balance at Mar. 31, 2021	923,415						$ 760,151	$ 0	$ 163,264
Increase (Decrease) in Temporary Equity [Roll Forward]
Issuance of convertible preferred stock, net (in shares)								7,857,000
Issuance of convertible preferred stock, net	109,782							$ 109,782
Ending balance (in shares) at Jun. 30, 2021							72,226,000	7,857,000	44,958,000
Ending balance at Jun. 30, 2021	1,033,197						$ 760,151	$ 109,782	$ 163,264
Beginning balance (in shares) at Mar. 31, 2021			43,342,000
Beginning balance at Mar. 31, 2021	(417,657)		$ 0	27,513	(447,259)	2,089
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Rollover equity in consideration of net assets acquired	310			310
Stock-based compensation (in shares)			571,000
Stock-based compensation	11,201			11,201
Stock option exercises (in shares)			84,000
Stock option exercises	281			281
Foreign currency translation losses, net	369					369
Net loss	(24,334)				(24,334)
Ending balance (in shares) at Jun. 30, 2021			43,997,000
Ending balance at Jun. 30, 2021	(429,830)		$ 0	39,305	(471,593)	2,458
Increase (Decrease) in Temporary Equity [Roll Forward]
Conversion of convertible preferred stock to common stock upon closing of initial public offering (in shares)							(72,226,000)	(7,857,000)	(44,958,000)
Conversion of convertible preferred stock to common stock upon closing of initial public offering	(1,033,197)						$ (760,151)	$ (109,782)	$ (163,264)
Ending balance (in shares) at Sep. 30, 2021							0	0	0
Ending balance at Sep. 30, 2021	0						$ 0	$ 0	$ 0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Conversion of convertible preferred stock to common stock upon closing of initial public offering (in shares)			125,041,000
Conversion of convertible preferred stock to common stock upon closing of initial public offering	1,033,197		$ 2	1,033,195
Issuance of common stock upon closing of initial public offering, net of issuance costs and underwriters fees (in shares)			21,882,000
Issuance of common stock upon closing of initial public offering, net of issuance costs and underwriters fees	340,884			340,884
Common stock issued in private placement (in shares)			4,412,000
Common stock issued in private placement	75,000			75,000
Stock-based compensation	4,745			4,745
Stock option exercises (in shares)			24,000
Stock option exercises	137			137
Foreign currency translation losses, net	(3,430)					(3,430)
Net loss	(36,906)				(36,906)
Ending balance (in shares) at Sep. 30, 2021			195,356,000
Ending balance at Sep. 30, 2021	983,797		$ 2	1,493,266	(508,499)	(972)
Beginning balance (in shares) at Dec. 31, 2021		0	195,384,000
Beginning balance at Dec. 31, 2021	985,648	$ 0	$ 2	1,500,643	(513,230)	(1,767)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Stock-based compensation	$ 6,135			6,135
Stock option exercises (in shares)	126,000		126,000
Stock option exercises	$ 723			723
Foreign currency translation losses, net	(664)					(664)
Net loss	(13,309)				(13,309)
Ending balance (in shares) at Mar. 31, 2022		0	195,510,000
Ending balance at Mar. 31, 2022	978,533	$ 0	$ 2	1,507,501	(526,539)	(2,431)
Increase (Decrease) in Temporary Equity [Roll Forward]
Accretion of Series B convertible preferred stock to redemption value	0
Beginning balance (in shares) at Dec. 31, 2021		0	195,384,000
Beginning balance at Dec. 31, 2021	985,648	$ 0	$ 2	1,500,643	(513,230)	(1,767)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Rollover equity in consideration of net assets acquired	$ 0
Repurchase and retirement of common shares (in shares)	(2,097,108)
Repurchase and retirement of common stock	$ (21,900)
Foreign currency translation losses, net	(15,811)
Net loss	(42,043)
Ending balance (in shares) at Sep. 30, 2022		0	193,938,000
Ending balance at Sep. 30, 2022	929,136	$ 0	$ 2	1,501,985	(555,273)	(17,578)
Beginning balance (in shares) at Mar. 31, 2022		0	195,510,000
Beginning balance at Mar. 31, 2022	978,533	$ 0	$ 2	1,507,501	(526,539)	(2,431)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for Employee Stock Purchase Plan (in shares)			218,000
Issuance of common stock for Employee Stock Purchase Plan	1,804			1,804
Stock-based compensation	$ 6,508			6,508
Stock option exercises (in shares)	96,000		96,000
Stock option exercises	$ 381			381
Repurchase and retirement of common shares (in shares)			(296,000)
Repurchase and retirement of common stock	(2,665)			(2,665)
Foreign currency translation losses, net	(8,169)					(8,169)
Net loss	(12,881)				(12,881)
Ending balance (in shares) at Jun. 30, 2022		0	195,528,000
Ending balance at Jun. 30, 2022	963,511	$ 0	$ 2	1,513,529	(539,420)	(10,600)
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Issuance of common stock for Employee Stock Purchase Plan	(50)			(50)
Common stock issued upon vesting of restricted stock units (in shares)			116,000
Stock-based compensation	$ 7,133			7,133
Stock option exercises (in shares)	95,000		95,000
Stock option exercises	$ 571			571
Repurchase and retirement of common shares (in shares)	(1,801,062)		(1,801,000)
Repurchase and retirement of common stock	$ (19,198)			(19,198)
Foreign currency translation losses, net	(6,978)					(6,978)
Net loss	(15,853)				(15,853)
Ending balance (in shares) at Sep. 30, 2022		0	193,938,000
Ending balance at Sep. 30, 2022	$ 929,136	$ 0	$ 2	$ 1,501,985	$ (555,273)	$ (17,578)

Condensed Consolidated Statem_3

Condensed Consolidated Statements of Convertible Preferred Stock and Stockholders’ Equity (Deficit) (unaudited) (Parenthetical) $ in Thousands	3 Months Ended
	Sep. 30, 2022 USD ($)
Statement of Stockholders' Equity [Abstract]
Stock issuance costs	$ 31,102

Condensed Consolidated Statem_4

Condensed Consolidated Statements of Cash Flows (unaudited) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Cash flows provided by operating activities:
Net loss	$ (42,043)	$ (77,235)
Adjustments to reconcile net loss to net cash provided by operating activities:
Loss on debt extinguishment	0	28,714
Depreciation and amortization	82,524	73,917
Capitalized software abandonment	580	0
Amortization of deferred financing costs and non-cash interest	1,622	4,362
Deferred taxes	(6,855)	(2,831)
Stock-based compensation expense	19,776	16,849
Other non-cash items	3,365	1,221
Changes in operating assets and liabilities, net of effects of acquisitions:
Accounts receivable, net	(11,722)	(7,047)
Prepaid expenses and other current assets	(7,151)	(11,413)
Other non-current assets	(1,313)	(11,526)
Accounts payable	(1,450)	(1,886)
Accrued expenses and other	(1,308)	(6,802)
Deferred revenue	2,503	7,924
Other long-term liabilities	(916)	(574)
Net cash provided by operating activities	37,612	13,673
Cash flows used in investing activities:
Purchases of property and equipment	(2,155)	(1,932)
Capitalization of software costs	(11,440)	(9,065)
Acquisition of companies, net of cash acquired	0	(183,242)
Net cash used in investing activities	(13,595)	(194,239)
Cash flows provided by (used in) financing activities:
Payments on debt	(6,125)	(837,082)
Proceeds from long-term debt	0	496,466
Deferred financing costs	0	(5,689)
Exercise of stock options	1,675	1,153
Proceeds from preferred stock issuance, net	0	109,782
Proceeds from common stock issuance, net	0	415,884
Proceeds from common stock issuance for Employee Stock Purchase Plan	1,754	0
Repurchase and retirement of common stock	(21,863)	0
Net cash provided by (used in) financing activities	(24,559)	180,514
Effect of foreign currency exchange rate changes on cash	(1,796)	59
Net increase (decrease) in cash and cash equivalents and restricted cash	(2,338)	7
Cash and cash equivalents and restricted cash:
Beginning of period	97,559	98,338
End of period	95,221	98,345
Supplemental disclosures of cash flow information:
Cash paid for interest	19,460	25,090
Cash paid for income taxes	1,950	1,544
Supplemental disclosures of noncash investing and financing activities:
Rollover equity in consideration of net assets acquired	0	726
Accretion of Series B convertible preferred stock to redemption value	$ 0	$ 15,105

Nature of the Business

Nature of the Business	9 Months Ended
	Sep. 30, 2022
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Nature of the Business	Nature of the BusinessEverCommerce Inc. and subsidiaries (the “Company” or “EverCommerce”) is a leading provider of integrated software-as-a-service (“SaaS”) solutions or services for service-based small- and medium-sized businesses (“SMBs”). Our platform spans across the full lifecycle of interactions between consumers and service professionals with vertical-specific applications. Today, the Company serves over 600,000 customers across three core verticals: Home Services; Health Services; and Fitness & Wellness Services. Within the core verticals, customers operate within numerous micro-verticals, ranging from home service professionals, such as construction contractors and home maintenance technicians, to physician practices and therapists in the Health Services industry, to personal trainers and salon owners in the Fitness & Wellness sectors. The platform provides vertically-tailored SaaS solutions that address service SMBs’ increasingly nuanced demands, as well as highly complementary solutions that complete end-to-end offerings, allowing service SMBs and EverCommerce to succeed in the market, and provide end consumers more convenient service experiences. The Company was incorporated in Delaware on September 29, 2016, and began operations on October 17, 2016 (Inception). The Company is headquartered in Denver, Colorado, and has operations across the United States, Canada, Jordan, United Kingdom, Australia and New Zealand. The Company changed its name from PaySimple Holdings, Inc. to EverCommerce Inc. as of December 14, 2020.

Summary of Significant Accounti

Summary of Significant Accounting Policies	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Summary of Significant Accounting Policies	Summary of Significant Accounting Policies Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements for the year ended December 31, 2021 and the related notes (“Annual Report on Form 10-K”). The December 31, 2021 condensed consolidated balance sheet was derived from our audited consolidated financial statements as of that date. Our unaudited interim condensed consolidated financial statements include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair statement of the unaudited condensed consolidated financial statements. All intercompany accounts and transactions have been eliminated in consolidation. There have been no significant changes in accounting policies during the nine months ended September 30, 2022 from those disclosed in the annual consolidated financial statements for the year ended December 31, 2021 and the related notes. The operating results for the three and nine months ended September 30, 2022 are not necessarily indicative of the results expected for the full year ending December 31, 2022. Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain amounts reported in the unaudited condensed consolidated financial statements, including the accompanying notes. The Company bases its estimates on historical factors, current circumstances, and the experience and judgment of management. The Company evaluates its estimates and assumptions on an ongoing basis. Actual results could differ from those estimates. Significant estimates reflected in the consolidated financial statements include revenue recognition, allowance for doubtful accounts, valuation allowances with respect to deferred tax assets, assumptions underlying the fair value used in the calculation of stock-based compensation, valuation of intangible assets and goodwill and useful lives of tangible and intangible assets, among others. Emerging Growth Company As an emerging growth company (“EGC”), the Jumpstart Our Business Startups Act (“JOBS Act”) allows the Company to delay adoption of new or revised accounting pronouncements applicable to public companies until such pronouncements are applicable to private companies. The Company has elected to use the extended transition period under the JOBS Act until the earlier of the date that it is (i) no longer an EGC or (ii) affirmatively and irrevocably opts out of the extended transition period provided in the JOBS Act. As a result, the financial statements may not be comparable to companies that comply with the new or revised accounting pronouncements as of public company effective dates. The adoption dates are discussed below to reflect this election within the “Recently Issued Accounting Pronouncements” section. Recently Issued Accounting Pronouncements not yet Adopted In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) , which is intended to improve financial reporting about leasing transactions. The ASU affects all companies that lease assets such as real estate and equipment for a period for more than 12 months, and will require organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. The updated standard will be effective for annual reporting periods beginning after December 15, 2021 and interim periods the following year. The Company will adopt this standard in the fourth quarter of 2022. Based on management’s current assessment, the impact of adoption will result in an additional right-of-use asset and corresponding lease liability presented on the consolidated balance sheet, largely comprised of its future real estate lease obligations along with any embedded leases in service contracts. Based on our assessment through September 30, 2022, we expect no material impact to the consolidated statements of operations and comprehensive loss; however, management’s analysis of the impact of adoption is not complete. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326); Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost, which includes the Company’s accounts receivable and contract assets. This updated standard will be effective for annual reporting periods beginning after December 15, 2022. The Company is currently evaluating the impact the adoption of this standard will have on its financial statements. In October 2021, the FASB issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which amends the guidance in ASC 805 to require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. FASB’s objective in issuing the ASU is to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity and inconsistency related to both the recognition of an acquired contract liability and payment terms’ effects on subsequent revenue recognized by the acquirer. This updated standard will be effective for annual reporting periods beginning after December 15, 2022. Early adoption is permitted. The impact of adoption is unknown as it will be based on any potential acquisitions consummated in the year of adoption.

Acquisitions

Acquisitions	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Acquisitions	Acquisitions 2021 Acquisitions During 2021 and in the nine months ended September 30, 2021, the Company completed five and four business acquisitions, respectively, in conjunction with the execution of its long-term plans and objectives in building a service commerce platform supporting the success of SMBs. All of the acquisitions qualified as business combinations under ASC 805. Accordingly, the Company recorded all assets acquired and liabilities assumed at their acquisition date fair values, with any excess consideration recognized as goodwill. Goodwill primarily represents the value associated with the assembled workforce, and expected synergies subsumed into goodwill. Assets acquired and liabilities assumed in connection with each acquisition have been recorded at their fair values. Fair values were determined by management using the assistance of third-party valuation specialists. The valuation methods used to determine the fair value of intangible assets included the income approach—relief from royalty method for developed technology and trade name, the income approach—excess earnings method for customer relationships and the comparative business valuation method for non-compete agreements. A number of assumptions and estimates were involved in the application of these valuation methods, including revenue forecasts, expected competition, costs of revenues, obsolescence, tax rates, capital spending, discount rates and working capital changes. Cash flow forecasts were generally based on pre-acquisition forecasts coupled with estimated revenues and cost synergies available to a market participant. The Company’s condensed consolidated statements of operations and comprehensive loss include $8.4 million of acquisition related transaction costs in general and administrative for acquisitions consummated in 2021, with $4.1 million and $6.8 million incurred in the three and nine months ended September 30, 2021, respectively. Each acquisition allows for an adjustment to the purchase price to be made subsequent to the transaction closing date based on the actual amount of working capital and cash delivered to the Company. The consideration paid and purchase price allocations disclosed reflect the effects of these adjustments. The allocation of purchase consideration related to certain 2021 acquisitions is considered preliminary. The following table summarizes the estimated fair values of consideration transferred, assets acquired and liabilities assumed for each acquisition in 2021: Briostack PulseM MDTech Timely DrChrono Total (in thousands) Cash $ 34,441 $ 34,430 $ 15,751 $ 99,820 $ 181,919 $ 366,361 Rollover equity 726 — — — — 726 Total consideration $ 35,167 $ 34,430 $ 15,751 $ 99,820 $ 181,919 $ 367,087 Net assets acquired: Cash and cash equivalents $ 17 $ — $ 100 $ 1,170 $ 130 $ 1,417 Accounts receivable, trade 156 — 175 290 3,344 3,965 Other receivables 222 151 48 95 149 665 Contract Assets — — — — 1,172 1,172 Prepaid expenses and other current assets 53 32 34 128 3,115 3,362 Property and equipment 22 4 16 219 226 487 Deposits and other long-term assets 144 3 — 52 23 222 Intangible—developed technology 1,360 2,380 1,640 7,014 8,480 20,874 Intangible—customer relationships 4,800 12,510 5,830 28,836 53,970 105,946 Intangible—trade name 390 260 200 1,414 3,250 5,514 Intangible—non-compete agreements 23 10 10 63 10 116 Goodwill 28,274 22,866 7,899 69,737 126,947 255,723 Deferred tax asset, net 1 — 2 3,397 — 3,400 Accounts payable (33) (113) (44) (230) (2,749) (3,169) Other Current Liabilities (28) — — (670) (2,086) (2,784) Accrued expenses and other (206) (99) (116) (940) (2,948) (4,309) Deferred tax liability, net — (3,538) — (10,463) (10,740) (24,741) Deferred revenue (28) (36) (43) (292) (374) (773) Total net assets acquired $ 35,167 $ 34,430 $ 15,751 $ 99,820 $ 181,919 $ 367,087 Briostack On January 19, 2021, the Company acquired 100% of the interest of Briostack LLC dba Briostack (“Briostack”), a provider of operational management software to pest control businesses, for $35.2 million. Under the terms of the purchase agreement, certain members of Briostack received 45,454 shares of common stock rollover equity. The Company finalized the fair value of the shares at $0.7 million in the quarter ended June 30, 2021 by applying a market approach. The fair value of the rollover equity is reflected in the total consideration above. PulseM On March 17, 2021, the Company acquired 100% of the interest of Speetra, Inc. dba PulseM (“PulseM”), a provider of enterprise-level reputation management software for small businesses, for $34.4 million. MDTech On July 8, 2021, the Company acquired 100% of the interest of PM Ventures, LLC dba MDTech (“MDTech”), a provider of electronic charge capture solutions to physicians via its SaaS-based MD Coder application and suite of add-ons, for $15.8 million. Timely On July 8, 2021, the Company acquired 100% of the interest of Timely Ltd. (“Timely”), a booking and business management software company, for $99.8 million. Timely is based in New Zealand and has operations in the United Kingdom and Australia, as well. DrChrono On November 18, 2021, the Company acquired 100% of the interest of DrChrono Inc. (“DrChrono”), an electronic health record and practice management provider, for $181.9 million. Pro Forma Results of Acquisitions (unaudited) The following table presents unaudited pro forma consolidated results of operations for the three and nine months ended September 30, 2022 and 2021, as if the aforementioned 2021 acquisitions had occurred as of January 1, 2021. The Company did not consummate any transactions during the three and nine months ended September 30, 2022; accordingly, no adjustments have been made to the results reported for that period. The pro forma information includes the business combination accounting effects resulting from these acquisitions, including interest expense of $4.9 million and $11.7 million for the three and nine months ended September 30, 2021, respectively, to account for funds borrowed earlier, issuance of our common stock at earlier dates which impacts the calculation of basic and diluted net loss per share, removal of transaction costs of $4.1 million and $6.8 million for the three and nine months ended September 30, 2021, respectively, and additional amortization expense of $1.8 million and $8.4 million for the three and nine months ended September 30, 2021, respectively, resulting from the amortization of intangible assets beginning as of January 1, 2021. We prepared the pro forma financial information for the combined entities for comparative purposes only, and the information is not indicative of what actual results would have been if the acquisitions had occurred at the beginning of the periods presented, nor is the information intended to represent or be indicative of future results of operations. Three months ended Nine months ended 2022 Pro Forma 2021 Pro Forma 2022 Pro Forma 2021 Pro Forma (in thousands, except per share amounts) (unaudited) Total revenue $ 158,126 $ 140,362 $ 458,948 $ 395,273 Net loss $ (15,853) $ (40,775) $ (42,043) $ (94,003) Adjustments to net loss per share (see Note 10) — — — (15,105) Net loss attributable to common stockholders $ (15,853) $ (40,775) $ (42,043) $ (109,108) Basic and diluted net loss per share attributable to common stockholders $ (0.08) $ (0.22) $ (0.22) $ (1.19)

Revenue

Revenue	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Revenue	Revenue Disaggregation of Revenue The following tables present a disaggregation of our revenue from contracts with customers by revenue recognition pattern and geographical market: Three months ended Nine months ended 2022 2021 2022 2021 (in thousands) By pattern of recognition (timing of transfer of services): Point in time $ 14,496 $ 13,743 $ 40,112 $ 37,324 Over time 143,630 114,791 418,836 317,166 Total $ 158,126 $ 128,534 $ 458,948 $ 354,490 By geographical market: United States $ 146,492 $ 118,721 $ 418,510 $ 325,179 International 11,634 9,813 40,438 29,311 Total $ 158,126 $ 128,534 $ 458,948 $ 354,490 Contract Balances Supplemental balance sheet information related to contracts from customers as of: September 30, December 31, 2022 2021 (in thousands) Accounts receivable, net $ 49,762 $ 40,514 Contract assets $ 13,782 $ 11,039 Deferred revenue $ 25,300 $ 22,992 Customer deposits $ 10,176 $ 9,828 Long-term deferred revenue $ 2,596 $ 2,803 Accounts receivable, net: Accounts receivable represent rights to consideration in exchange for products or services that have been transferred by us, when payment is unconditional and only the passage of time is required before payment is due. Contract assets: Contract assets represent rights to consideration in exchange for products or services that have been transferred (i.e., the performance obligation or portion of the performance obligation has been satisfied), but payment is conditional on something other than the passage of time. These amounts typically relate to contracts that include on-premise licenses and professional services where the right to payment is not present until completion of the contract or achievement of specified milestones and the fair value of products or services transferred exceed this constraint. Contract liabilities : Contract liabilities represent our obligation to transfer products or services to a customer for which consideration has been received in advance of the satisfaction of performance obligations. Short-term contract liabilities are included within deferred revenue on the consolidated balance sheets. Long-term contract liabilities are included within long-term deferred revenue on the consolidated balance sheets. Revenue recognized from the contract liability balance at December 31, 2021 was $20.9 million for the nine months ended September 30, 2022. Customer deposits : Customer deposits relate to payments received in advance for contracts, which allow the customer to terminate a contract and receive a pro rata refund for the unused portion of payments received to date. In these arrangements, we have concluded there are no enforceable rights and obligations during the period in which the option to cancel is exercisable by the customer and therefore the consideration received is recorded as a customer deposit liability. Remaining Performance Obligations Remaining performance obligations represent the transaction price of unsatisfied or partially satisfied performance obligations within contracts with an original expected contract term that is greater than one year for which fulfillment of the contract has started as of the end of the reporting period. Variable consideration accounted for under the variable consideration allocation exception associated with unsatisfied performance obligations or an unsatisfied promise that forms part of a single performance obligation under application of the series guidance have been excluded. Remaining performance obligations generally relate to those which are stand-ready in nature, as found within the subscription and marketing technology solutions revenue streams. The aggregate amount of transaction consideration allocated to remaining performance obligations as of September 30, 2022, was $22.3 million, which is comprised of contracts where the contract term under ASC 606 is in excess of one year. The Company expects to recognize approximately 59% of its remaining performance obligations as revenue within the next year, 27% of its remaining performance obligations as revenue the subsequent year, 10% of its remaining performance obligations as revenue in the third year, and the remainder during the two year period thereafter. Cost to Obtain and Fulfill a Contract The Company incurs certain costs to obtain contracts, principally sales and third-party commissions, which the Company capitalizes when the liability has been incurred if they are (i) incremental costs of obtaining a contract, (ii) expected to be recovered and (iii) have an expected amortization period that is greater than one year (as the Company has elected the practical expedient to expense any costs to obtain a contract when the liability is incurred if the amortization period of such costs would be one year or less). Assets resulting from costs to obtain contracts are included within prepaid expenses and other current assets for short-term balances and other non-current assets for long-term balances on the Company’s consolidated balance sheets. The costs to obtain contracts are amortized over 5 years, which corresponds with the useful life of the related capitalized software. Short-term assets were $6.2 million and $4.8 million at September 30, 2022 and December 31, 2021, respectively, and long-term assets were $14.3 million and $11.9 million at September 30, 2022 and December 31, 2021, respectively. The Company recorded amortization expense within sales and marketing on the condensed consolidated statements of operations and comprehensive loss of $1.1 million and $0.7 million for the three months ended September 30, 2022 and 2021, respectively, and $3.1 million and $2.0 million for the nine months ended September 30, 2022 and 2021, respectively. The Company recorded amortization expense within cost of revenues on the condensed consolidated statements of operations and comprehensive loss of $0.4 million and $0.3 million for the three months ended September 30, 2022 and 2021, respectively, and $1.2 million and $0.7 million for the nine months ended September 30, 2022 and 2021, respectively. The Company has concluded that there are no other material costs incurred in fulfillment of customer contracts that are not accounted for under other GAAP, which meet the capitalization criteria under ASC 606 and FASB ASC Topic 340-40, Accounting for Other Assets and Deferred Costs (“ASC 340-40”). The Company has elected to

Goodwill

Goodwill	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Goodwill	Goodwill Goodwill activity consisted of the following for the nine months ended September 30, 2022 (in thousands): Balance at December 31, 2021 $ 921,416 Measurement period adjustments (1) (573) Effect of foreign currency exchange rate changes (13,600) Balance at September 30, 2022 $ 907,243 (1) The $0.6 million of measurement period adjustments relates to acquisitions consummated during the year ended December 31, 2021.

Intangible Assets

Intangible Assets	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Intangible Assets	Intangible Assets Intangible assets consisted of the following as of: September 30, 2022 Useful Gross Carrying Accumulated Net Book (in thousands) Customer relationships 3-20 years $ 604,914 $ 245,509 $ 359,405 Developed technology 2-12 years 105,598 54,893 50,705 Trade name 3-10 years 38,095 18,413 19,682 Non-compete agreements 2-5 years 2,394 1,953 441 Total $ 751,001 $ 320,768 $ 430,233 December 31, 2021 Useful Gross Carrying Accumulated Net Book (in thousands) Customer relationships 3-20 years $ 607,625 $ 187,556 $ 420,069 Developed technology 2-12 years 106,162 42,215 63,947 Trade name 3-10 years 38,218 14,540 23,678 Non-compete agreements 2-5 years 2,409 1,568 841 Total $ 754,414 $ 245,879 $ 508,535 Amortization expense was $25.2 million and $24.2 million for the three months ended September 30, 2022 and 2021, respectively, and $75.7 million and $68.7 million for the nine months ended September 30, 2022 and 2021, respectively.

Property and Equipment

Property and Equipment	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Property and Equipment	Property and Equipment Property and equipment consisted of the following as of: September 30, December 31, 2022 2021 (in thousands) Computer equipment and software $ 9,918 $ 8,191 Furniture and fixtures 3,560 3,667 Leasehold improvements 11,928 12,032 Total property and equipment 25,406 23,890 Less accumulated depreciation (12,899) (10,381) Property and equipment, net $ 12,507 $ 13,509 Depreciation expense was $1.0 million for each of the three months ended September 30, 2022 and 2021 and $3.1 million and $2.8 million for the nine months ended September 30, 2022 and 2021, respectively.

Capitalized Software

Capitalized Software	9 Months Ended
	Sep. 30, 2022
Research and Development [Abstract]
Capitalized Software	Capitalized Software Capitalized software consisted of the following as of: September 30, December 31, 2022 2021 (in thousands) Capitalized software $ 42,746 $ 31,960 Less: accumulated amortization (11,646) (7,960) Capitalized software, net $ 31,100 $ 24,000 Amortization expense was $1.4 million and $0.9 million for the three months ended September 30, 2022 and 2021, respectively, and $3.7 million and $2.4 million for the nine months ended September 30, 2022 and 2021, respectively. During the three and nine months ended September 30, 2022 the Company recorded a charge to general and administrative on the accompanying condensed consolidated statements of operations and comprehensive loss for $0.1 million and $0.6 million, respectively, related to capitalized features no longer expected to be used.

Long-Term Debt

Long-Term Debt	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Long-Term Debt	Long-Term Debt Long-term debt consisted of the following as of: September 30, December 31, 2022 2021 (in thousands) Term notes with interest payable monthly, interest rate at Adjusted LIBOR or Alternative Base Rate, plus an applicable mar gin of 3.25% (5.77% at September 30, 2022) quarterly principal payments of 0.25% of original principal balance with balloon payment due July 2028 $ 544,500 $ 548,625 Revolver with interest payable monthly, interest rate at Adjusted LIBOR or Alternative Base Rate, plus an applicable margin of 3.25% (6.37% at September 30, 2022), and outstanding balance due July 2026 — — Subordinated unsecured promissory note related to acquisition of Service Nation, Inc., interest paid-in-kind, interest rate at 8.5% with balloon payment due September 2022 — 2,866 Subordinated unsecured promissory note related to acquisition of Technique Fitness, Inc. D/B/A Club OS, interest paid-in-kind, interest rate at 7% with balloon payment due December 2022 2,797 2,655 Principal debt 547,297 554,146 Deferred financing costs on long-term debt (5,131) (5,826) Discount on long-term debt (1,878) (2,193) Total debt 540,288 546,127 Less current maturities 8,282 10,943 Long-term portion $ 532,006 $ 535,184 On July 6, 2021, the Company entered into a credit facility (“Credit Agreement”) that includes term loans in an aggregate principal amount of $350.0 million (“Initial Term Loans”), a revolver with a capacity of $190.0 million (“Revolver”) and a sub-limit of the Revolver available for letters of credit up to an aggregate face amount of $20.0 million. The Initial Term Loans were used to retire the Company’s debt arrangements that were outstanding prior to the Initial Public Offering (“IPO”). A loss on debt extinguishment related to the refinancing of the Company’s debt arrangements was recorded during the three months ended September 30, 2021 totaling $28.7 million. As of November 2021, the Company had $35.0 million outstanding under the Revolver, and borrowed the remaining capacity of the Revolver to fund the acquisition of DrChrono. Subsequently in the same month, the Company received additional term loans in an aggregate principal amount of $200.0 million (together with the Initial Term Loans, the “Term Loans”), the proceeds of which were used to repay the outstanding principal balance of the Revolver of $190.0 million and for general corporate purposes. The Initial Term Loans, Revolver and Additional Term Loans are collectively referred to herein as the (“Credit Facilities”). The Company determines the fair value of long-term debt based on trading prices for its debt if available. As of September 30, 2022, the Company obtained trading prices for the term notes outstanding. However, as such trading prices require significant unobservable inputs to the pricing model, such instruments are classified as Level 2. If no such trading prices are available, the Company determines the fair value of long-term debt using discounted cash flows, applying current interest rates and current credit spreads, based on its own credit risk. The fair value amounts were approximately $520.1 million and $552.8 million as of September 30, 2022 and December 31, 2021, respectively. As of January 1, 2021, the Company also had outstanding subordinated promissory notes (“Legacy Subordinated Notes”) that included paid-in-kind (“PIK”) interest. The interest on the Legacy Subordinated Notes is all PIK and is due upon maturity. Total PIK interest was $0.1 million for each of the three months ended September 30, 2022 and 2021, and $0.3 million for each of the nine months ended September 30, 2022 and 2021. The company repaid the outstanding principal and PIK interest upon maturity of one of the Legacy Subordinated Notes for $2.0 million and $1.0 million, respectively, during the three months ended September 30, 2022. The remaining Legacy Subordinated Notes outstanding principal and PIK interest will be repaid upon maturity during the fourth quarter of 2022. The Company’s Credit Facilities are subject to certain financial and nonfinancial covenants and are secured by substantially all assets of the Company. As of September 30, 2022, the Company was in compliance with all of its covenants. Aggregate maturities of the Company’s debt for the years ending December 31 are as follows as of September 30, 2022 (in thousands): Years ending December 31: 2022 (remaining three months) $ 4,211 2023 5,500 2024 5,500 2025 5,500 2026 5,500 Thereafter 521,125 Total aggregate maturities of the Company’s debt $ 547,336

Equity

Equity	9 Months Ended
	Sep. 30, 2022
Equity [Abstract]
Equity	Equity On May 5, 2021, the Company amended its Certificate of Incorporation (“Third Amended and Restated Certificate of Incorporation”) to increase the number of authorized shares of Preferred Stock from 125,000,000 shares to 140,000,000 shares of Preferred Stock, $0.00001 par value per share, of which 50,000,000 were designated as Series A, 75,000,000 were designated as Series B and 15,000,000 were designated as Series C as of such date. Each share of Series A, Series B and Series C could have been converted into common stock at any time, at the option of the holder, based on a prescribed formula set forth in the Company’s Third Amended and Restated Certificate of Incorporation. In the event of a liquidation, dissolution, winding up of the Company or other similar event, liquidation payments would have first been made to the holders of Series B, then to Series C, then to Series A. In May 2021, the Company issued 7.9 million shares of Series C for proceeds of $109.8 million net of issuance costs. In accordance with ASC 480, Distinguishing Liabilities from Equity , if the carrying value of redeemable preferred stock is less than its redemption value, redeemable preferred stock shall be accreted to its redemption value if it is probable it will become redeemable. Prior to March 15, 2021, the Company concluded it was probable that the Series B would become redeemable due to the passage of time. However, after that date the Company concluded that it was no longer probable that the Series B would become redeemable due to the increased likelihood of a successful IPO prior to February 23, 2026. The Company’s Series B accruing dividends comprised a component of the redemption value of such stock. The Company recorded the accretion of Series B through March 15, 2021, by increasing its carrying value and recording a corresponding reduction of additional paid-in capital in the amount of $15.1 million for the nine months ended September 30, 2021. Immediately prior to the closing of the IPO, the Company filed an Amended and Restated Certificate of Incorporation on July 6, 2021 with the Secretary of State of the State of Delaware to authorize the issuance up to 2,050,000,000 shares, par value $0.00001 per share, consisting of 2,000,000,000 shares of common stock and 50,000,000 shares of preferred stock. In connection with the IPO, all of the Company’s then outstanding convertible preferred stock converted into shares of common stock on a one-for-one basis. Upon conversion of the convertible preferred stock, the Company reclassified the carrying value of the convertible preferred stock to common stock and additional paid-in capital. On June 14, 2022, our Board of Directors approved a stock repurchase program (“The Repurchase Program”) wi th authorization to purchase up to $50.0 million in shares of the Company’s common stock through the expiration of the program on December 21, 2022. Repurchases under the program may be made in the open market, in privately negotiated transactions or otherwise, with the amount and timing of repurchases to be determined at the Company’s discretion, depending on market conditions and corporate needs. This program does not obligate the Company to acquire any particular amount of common stock and may be modified, suspended or terminated at any time at the discretion of the Board of Directors. The Company expects to fund repurchases with existing cash on hand. The Company repurchased and retired 1,801,062 and 2,097,108 shares of common stock for $19.2 million and $21.9 million, including transaction fees, d uring the three and nine months ended September 30, 2022, respectively. On November 7, 2022, our Board of Directors approved an expansion of the Repurchase Program with authorization to purchase up to an additional $50.0 million in shares of the Company’s common stock ($100.0 million total) and an extension to the expiration of the Repurchase Program through December 31, 2023.

Stock-Based Compensation

Stock-Based Compensation	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Stock-Based Compensation	Stock-Based Compensation In 2016, the Company adopted the 2016 Equity Incentive Plan (the “2016 Plan”). The 2016 Plan provided for the granting of stock-based awards, including stock options, stock appreciation rights, restricted or unrestricted stock awards, phantom stock, performance awards, and other stock-based awards. In connection with the IPO, the Company’s board of directors adopted, and the Company’s stockholders approved, the 2021 Incentive Award Plan (the “2021 Plan”), which became effective immediately prior to the effectiveness of the registration statement for the Company’s IPO and, as a result of which, the Company can no longer make awards under the 2016 Plan. The 2021 Plan provides for the issuance of incentive stock options, non-qualified stock options, stock awards, stock units, stock appreciation rights and other stock-based awards. The number of shares initially reserved for issuance under the 2021 Plan was 22,000,000 shares, inclusive of available shares previously reserved for issuance under the 2016 Plan. In addition, the number of shares reserved for issuance under the 2021 Plan is subject to an annual increase on the first day of each calendar year beginning on January 1, 2022 and ending on and including January 1, 2031, equal to the lesser of (i) 3% of the shares outstanding (on an as-converted basis) on the last day of the immediately preceding fiscal year and (ii) such smaller number of shares as determined by the Company’s board of directors, provided that no more than 22,000,000 shares may be issued upon the exercise of incentive stock options. Based on the Company’s outstanding shares of common stock as of December 31, 2021, as of January 1, 2022 the number of shares reserved for issuance under the 2021 Plan increased by 5.9 million. In connection with the IPO, the Company’s board of directors adopted the 2021 Employee Stock Purchase Plan (the “ESPP”). For more information on the ESPP, refer to Note 11 in the Annual Report on Form 10-K. The following table summarizes our restricted stock unit (“RSU”) and stock option activity for the nine months ended September 30, 2022: RSUs Options (in thousands) Outstanding as of January 1, 2022 541 16,444 Granted 1,521 1,480 Vested or exercised — (126) Cancelled or forfeited (10) (160) Outstanding as of March 31, 2022 2,052 17,638 Granted 211 146 Vested or exercised — (96) Cancelled or forfeited (163) (409) Outstanding as of June 30, 2022 2,100 17,279 Granted 95 54 Vested or exercised (116) (95) Cancelled or forfeited (56) (143) Outstanding as of September 30, 2022 2,023 17,095 As of September 30, 2022, total unrecognized compensation expense was $22.2 million and $28.7 million related to outstanding restricted stock units and outstanding stock options, respectively. Stock-based compensation expense was classified in the unaudited condensed consolidated statements of operations and comprehensive loss as follows: Three months ended Nine months ended 2022 2021 2022 2021 (in thousands) Cost of revenues $ 109 $ 173 $ 278 $ 178 Sales and marketing 380 160 1,127 298 Product development 501 295 1,389 437 General and administrative 6,143 4,117 16,982 15,936 Total stock-based compensation expense $ 7,133 $ 4,745 $ 19,776 $ 16,849

Net Loss Per Share Attributable

Net Loss Per Share Attributable to Common Stockholders	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Net Loss Per Share Attributable to Common Stockholders	Net Loss Per Share Attributable to Common Stockholders The following table presents the calculation of basic and diluted net loss per share for the Company’s common stock as of: Three months ended Nine months ended 2022 2021 2022 2021 (in thousands except share and per share amounts) Numerator: Net loss $ (15,853) $ (36,906) $ (42,043) $ (77,235) Accretion of Series B to redemption value — — — (15,105) Numerator for basic and diluted EPS – net loss attributable to common stockholders $ (15,853) $ (36,906) $ (42,043) $ (92,340) Denominator: Denominator for basic and diluted EPS – weighted-average shares of common stock outstanding used in computing net loss per share 194,542,764 187,994,437 195,205,260 91,655,461 Basic and diluted net loss per share attributable to common stockholders $ (0.08) $ (0.20) $ (0.22) $ (1.01) The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect as of: September 30, 2022 2021 Outstanding options to purchase common stock and unvested RSUs 19,118,295 16,967,629 Total anti-dilutive outstanding potential common stock 19,118,295 16,967,629

Fair Value of Financial Instrum

Fair Value of Financial Instruments	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Fair Value of Financial Instruments	Fair Value of Financial Instruments Fair value estimates of financial instruments are made at a specific point in time, based on relevant information about financial markets and specific financial instruments. As these estimates are subjective in nature, involving uncertainties and matters of significant judgment, they cannot be determined with precision. Changes in assumptions can significantly affect estimated fair value. The Company measures fair value as the price that would be received to sell an asset or paid to transfer a liability (an exit price) in an orderly transaction between market participants at the reporting date. The Company utilizes a three-tier hierarchy, which prioritizes the inputs used in the valuation methodologies in measuring fair value: • Level 1: Valuations based on quoted prices in active markets for identical assets or liabilities that an entity has the ability to access. • Level 2: Valuations based on quoted prices for similar assets or liabilities, quoted prices for identical assets or liabilities in markets that are not active, or other inputs that are observable or can be corroborated by observable data for substantially the full term of the assets or liabilities. • Level 3: Valuations based on inputs that are supported by little or no market activity and that are significant to the fair value of the assets or liabilities. The carrying value of cash and cash equivalents, accounts receivable, contract assets, contract liabilities and accounts payable approximate their fair value because of the short-term nature of these instruments. There were no transfers between fair value measurement levels during the three and nine months ended September 30, 2022 or 2021. The following table presents information about the Company's financial assets and liabilities measured at fair value on a recurring basis as of: September 30, 2022 Balance Sheet Classification Level 1 Level 2 Level 3 Total (in thousands) Asset: Money market $ 13,674 $ — $ — $ 13,674 Cash equivalents December 31, 2021 Balance Sheet Classification Level 1 Level 2 Level 3 Total (in thousands) Asset: Money market $ 14,855 $ — $ — $ 14,855 Cash equivalents Liability: Contingent consideration $ — $ — $ 675 $ 675 Other current liabilities The following is a reconciliation of the opening and closing balance for contingent consideration measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended September 30, 2022 (in thousands): Opening balance $ 675 Amounts settled through payment (657) Fair value adjustments (18) Ending balance $ —

Income Taxes

Income Taxes	9 Months Ended
	Sep. 30, 2022
Income Tax Disclosure [Abstract]
Income Taxes	Income Taxes Our provision for income taxes in interim periods is based on our estimated annual effective tax rate. We record cumulative adjustments in the quarter in which a change in the estimated annual effective rate is determined. The income tax benefit was $0.3 million and $1.0 million for the three months ended September 30, 2022 and 2021, respectively, and $6.0 million and $4.2 million for the nine months ended September 30, 2022 and 2021, respectively. Our effective income tax rate was 1.8% and 2.7% for the three months ended September 30, 2022 and 2021, respectively, and 12.4% and 5.1% for the nine months ended September 30, 2022 and 2021, respectively. The difference in the effective income tax rate for the three months ended September 30, 2022 as compared to the corresponding period in 2021 was primarily driven by the establishment of a valuation allowance for our New Zealand subsidiaries, which resulted in the exclusion of their results from the computation of the annual effective income tax rate. The difference in the effective income tax rate for the nine months ended September 30, 2022 as compared to the corresponding period in 2021 was primarily driven by discrete items, including an intercompany intellectual property sale, acquisition accounting, a California law change, a United Kingdom corporate income tax rate change, and the valuation allowance for our New Zealand subsidiaries, as described above. On August 16, 2022, the U.S. enacted the Inflation Reduction Act of 2022, which, among other things, implements a 15% minimum tax on book income of certain large corporations, a 1% excise tax on net stock repurchases and several tax incentives to promote clean energy. Based on our current analysis of the provisions, we do not believe this legislation will have a material impact on our consolidated financial statements.

Commitment and Contingencies

Commitment and Contingencies	9 Months Ended
	Sep. 30, 2022
Commitments and Contingencies Disclosure [Abstract]
Commitments and Contingencies	Commitments and ContingenciesFrom time to time, the Company may become involved in various lawsuits and legal proceedings which arise in the ordinary course of business. However, litigation is subject to inherent uncertainties, and an adverse result in these or other matters may arise from time to time that may harm our business. We are currently not aware of any such legal proceedings or claims that we believe will have, individually or in the aggregate, a material adverse effect on our business, financial condition or operating results.

Geographic Areas

Geographic Areas	9 Months Ended
	Sep. 30, 2022
Geographic Areas, Long-Lived Assets [Abstract]
Geographic Areas	Geographic Areas The following table sets forth long-lived assets by geographic area as of: September 30, December 31, 2022 2021 (in thousands) United States $ 36,015 $ 34,906 International $ 7,592 $ 2,603

Subsequent Events

Subsequent Events	9 Months Ended
	Sep. 30, 2022
Subsequent Events [Abstract]
Subsequent Events	Subsequent EventsEffective October 31, 2022, the Company entered into an interest rate swap agreement in connection with the Company’s Credit Facilities for a notional amount of $200.0 million to convert a portion of the Term Loan from a floating rate to a fixed rate (the “Swap Agreement”). The Swap Agreement has a term of 5 years with a fixed rate in the agreement of 4.2295%.

Summary of Significant Accoun_2

Summary of Significant Accounting Policies (Policies)	9 Months Ended
	Sep. 30, 2022
Accounting Policies [Abstract]
Basis of Presentation	Basis of Presentation The accompanying unaudited condensed consolidated financial statements have been prepared in accordance with accounting principles generally accepted in the United States (“GAAP”) for interim financial information. Certain information and disclosures normally included in consolidated financial statements prepared in accordance with GAAP have been condensed or omitted. Accordingly, these unaudited condensed consolidated financial statements should be read in conjunction with our audited consolidated financial statements for the year ended December 31, 2021 and the related notes (“Annual Report on Form 10-K”). The December 31, 2021 condensed consolidated balance sheet was derived from our audited consolidated financial statements as of that date. Our unaudited interim condensed consolidated financial statements include, in the opinion of management, all adjustments, consisting of normal and recurring items, necessary for the fair statement of the unaudited condensed consolidated financial statements. All intercompany accounts and transactions have been eliminated in consolidation. There have been no significant changes in accounting policies during the nine months ended September 30, 2022 from those disclosed in the annual consolidated financial statements for the year ended December 31, 2021 and the related notes.
Use of Estimates	Use of Estimates The preparation of unaudited condensed consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect certain amounts reported in the unaudited condensed consolidated financial statements, including the accompanying notes. The Company bases its estimates on historical factors, current circumstances, and the experience and judgment of management. The Company evaluates its estimates and assumptions on an ongoing basis. Actual results could differ from those estimates. Significant estimates reflected in the consolidated financial statements include revenue recognition, allowance for doubtful accounts, valuation allowances with respect to deferred tax assets, assumptions underlying the fair value used in the calculation of stock-based compensation, valuation of intangible assets and goodwill and useful lives of tangible and intangible assets, among others.
Recently Issued Accounting Pronouncements not yet Adopted	Recently Issued Accounting Pronouncements not yet Adopted In February 2016, the FASB issued ASU No. 2016-02, Leases (Topic 842) , which is intended to improve financial reporting about leasing transactions. The ASU affects all companies that lease assets such as real estate and equipment for a period for more than 12 months, and will require organizations that lease assets to recognize on the balance sheet the assets and liabilities for the rights and obligations created by those leases. The updated standard will be effective for annual reporting periods beginning after December 15, 2021 and interim periods the following year. The Company will adopt this standard in the fourth quarter of 2022. Based on management’s current assessment, the impact of adoption will result in an additional right-of-use asset and corresponding lease liability presented on the consolidated balance sheet, largely comprised of its future real estate lease obligations along with any embedded leases in service contracts. Based on our assessment through September 30, 2022, we expect no material impact to the consolidated statements of operations and comprehensive loss; however, management’s analysis of the impact of adoption is not complete. In June 2016, the FASB issued ASU No. 2016-13, Financial Instruments-Credit Losses (Topic 326); Measurement of Credit Losses on Financial Instruments, which requires the measurement and recognition of expected credit losses for financial assets held at amortized cost, which includes the Company’s accounts receivable and contract assets. This updated standard will be effective for annual reporting periods beginning after December 15, 2022. The Company is currently evaluating the impact the adoption of this standard will have on its financial statements. In October 2021, the FASB issued ASU No. 2021-08, Accounting for Contract Assets and Contract Liabilities from Contracts with Customers , which amends the guidance in ASC 805 to require that an acquirer recognize and measure contract assets and contract liabilities acquired in a business combination in accordance with Topic 606. FASB’s objective in issuing the ASU is to improve the accounting for acquired revenue contracts with customers in a business combination by addressing diversity and inconsistency related to both the recognition of an acquired contract liability and payment terms’ effects on subsequent revenue recognized by the acquirer. This updated standard will be effective for annual reporting periods beginning after December 15, 2022. Early adoption is permitted. The impact of adoption is unknown as it will be based on any potential acquisitions consummated in the year of adoption.

Acquisitions (Tables)

Acquisitions (Tables)	9 Months Ended
	Sep. 30, 2022
Business Combination and Asset Acquisition [Abstract]
Schedule of Consideration Transferred and Net Assets Acquired	The following table summarizes the estimated fair values of consideration transferred, assets acquired and liabilities assumed for each acquisition in 2021: Briostack PulseM MDTech Timely DrChrono Total (in thousands) Cash $ 34,441 $ 34,430 $ 15,751 $ 99,820 $ 181,919 $ 366,361 Rollover equity 726 — — — — 726 Total consideration $ 35,167 $ 34,430 $ 15,751 $ 99,820 $ 181,919 $ 367,087 Net assets acquired: Cash and cash equivalents $ 17 $ — $ 100 $ 1,170 $ 130 $ 1,417 Accounts receivable, trade 156 — 175 290 3,344 3,965 Other receivables 222 151 48 95 149 665 Contract Assets — — — — 1,172 1,172 Prepaid expenses and other current assets 53 32 34 128 3,115 3,362 Property and equipment 22 4 16 219 226 487 Deposits and other long-term assets 144 3 — 52 23 222 Intangible—developed technology 1,360 2,380 1,640 7,014 8,480 20,874 Intangible—customer relationships 4,800 12,510 5,830 28,836 53,970 105,946 Intangible—trade name 390 260 200 1,414 3,250 5,514 Intangible—non-compete agreements 23 10 10 63 10 116 Goodwill 28,274 22,866 7,899 69,737 126,947 255,723 Deferred tax asset, net 1 — 2 3,397 — 3,400 Accounts payable (33) (113) (44) (230) (2,749) (3,169) Other Current Liabilities (28) — — (670) (2,086) (2,784) Accrued expenses and other (206) (99) (116) (940) (2,948) (4,309) Deferred tax liability, net — (3,538) — (10,463) (10,740) (24,741) Deferred revenue (28) (36) (43) (292) (374) (773) Total net assets acquired $ 35,167 $ 34,430 $ 15,751 $ 99,820 $ 181,919 $ 367,087
Schedule of Pro Forma Results	The following table presents unaudited pro forma consolidated results of operations for the three and nine months ended September 30, 2022 and 2021, as if the aforementioned 2021 acquisitions had occurred as of January 1, 2021. The Company did not consummate any transactions during the three and nine months ended September 30, 2022; accordingly, no adjustments have been made to the results reported for that period. The pro forma information includes the business combination accounting effects resulting from these acquisitions, including interest expense of $4.9 million and $11.7 million for the three and nine months ended September 30, 2021, respectively, to account for funds borrowed earlier, issuance of our common stock at earlier dates which impacts the calculation of basic and diluted net loss per share, removal of transaction costs of $4.1 million and $6.8 million for the three and nine months ended September 30, 2021, respectively, and additional amortization expense of $1.8 million and $8.4 million for the three and nine months ended September 30, 2021, respectively, resulting from the amortization of intangible assets beginning as of January 1, 2021. We prepared the pro forma financial information for the combined entities for comparative purposes only, and the information is not indicative of what actual results would have been if the acquisitions had occurred at the beginning of the periods presented, nor is the information intended to represent or be indicative of future results of operations. Three months ended Nine months ended 2022 Pro Forma 2021 Pro Forma 2022 Pro Forma 2021 Pro Forma (in thousands, except per share amounts) (unaudited) Total revenue $ 158,126 $ 140,362 $ 458,948 $ 395,273 Net loss $ (15,853) $ (40,775) $ (42,043) $ (94,003) Adjustments to net loss per share (see Note 10) — — — (15,105) Net loss attributable to common stockholders $ (15,853) $ (40,775) $ (42,043) $ (109,108) Basic and diluted net loss per share attributable to common stockholders $ (0.08) $ (0.22) $ (0.22) $ (1.19)

Revenue (Tables)

Revenue (Tables)	9 Months Ended
	Sep. 30, 2022
Revenue from Contract with Customer [Abstract]
Disaggregation of Revenue	The following tables present a disaggregation of our revenue from contracts with customers by revenue recognition pattern and geographical market: Three months ended Nine months ended 2022 2021 2022 2021 (in thousands) By pattern of recognition (timing of transfer of services): Point in time $ 14,496 $ 13,743 $ 40,112 $ 37,324 Over time 143,630 114,791 418,836 317,166 Total $ 158,126 $ 128,534 $ 458,948 $ 354,490 By geographical market: United States $ 146,492 $ 118,721 $ 418,510 $ 325,179 International 11,634 9,813 40,438 29,311 Total $ 158,126 $ 128,534 $ 458,948 $ 354,490
Supplemental Balance Sheet Information	Supplemental balance sheet information related to contracts from customers as of: September 30, December 31, 2022 2021 (in thousands) Accounts receivable, net $ 49,762 $ 40,514 Contract assets $ 13,782 $ 11,039 Deferred revenue $ 25,300 $ 22,992 Customer deposits $ 10,176 $ 9,828 Long-term deferred revenue $ 2,596 $ 2,803

Goodwill (Tables)

Goodwill (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Goodwill	Goodwill activity consisted of the following for the nine months ended September 30, 2022 (in thousands): Balance at December 31, 2021 $ 921,416 Measurement period adjustments (1) (573) Effect of foreign currency exchange rate changes (13,600) Balance at September 30, 2022 $ 907,243 (1) The $0.6 million of measurement period adjustments relates to acquisitions consummated during the year ended December 31, 2021.

Intangible Assets (Tables)

Intangible Assets (Tables)	9 Months Ended
	Sep. 30, 2022
Goodwill and Intangible Assets Disclosure [Abstract]
Schedule of Finite-Lived Intangible Assets	Intangible assets consisted of the following as of: September 30, 2022 Useful Gross Carrying Accumulated Net Book (in thousands) Customer relationships 3-20 years $ 604,914 $ 245,509 $ 359,405 Developed technology 2-12 years 105,598 54,893 50,705 Trade name 3-10 years 38,095 18,413 19,682 Non-compete agreements 2-5 years 2,394 1,953 441 Total $ 751,001 $ 320,768 $ 430,233 December 31, 2021 Useful Gross Carrying Accumulated Net Book (in thousands) Customer relationships 3-20 years $ 607,625 $ 187,556 $ 420,069 Developed technology 2-12 years 106,162 42,215 63,947 Trade name 3-10 years 38,218 14,540 23,678 Non-compete agreements 2-5 years 2,409 1,568 841 Total $ 754,414 $ 245,879 $ 508,535

Property and Equipment (Tables)

Property and Equipment (Tables)	9 Months Ended
	Sep. 30, 2022
Property, Plant and Equipment [Abstract]
Schedule of Property and Equipment	Property and equipment consisted of the following as of: September 30, December 31, 2022 2021 (in thousands) Computer equipment and software $ 9,918 $ 8,191 Furniture and fixtures 3,560 3,667 Leasehold improvements 11,928 12,032 Total property and equipment 25,406 23,890 Less accumulated depreciation (12,899) (10,381) Property and equipment, net $ 12,507 $ 13,509

Capitalized Software (Tables)

Capitalized Software (Tables)	9 Months Ended
	Sep. 30, 2022
Research and Development [Abstract]
Schedule of Capitalized Software	Capitalized software consisted of the following as of: September 30, December 31, 2022 2021 (in thousands) Capitalized software $ 42,746 $ 31,960 Less: accumulated amortization (11,646) (7,960) Capitalized software, net $ 31,100 $ 24,000

Long-Term Debt (Tables)

Long-Term Debt (Tables)	9 Months Ended
	Sep. 30, 2022
Debt Disclosure [Abstract]
Schedule of Long-Term Debt	Long-term debt consisted of the following as of: September 30, December 31, 2022 2021 (in thousands) Term notes with interest payable monthly, interest rate at Adjusted LIBOR or Alternative Base Rate, plus an applicable mar gin of 3.25% (5.77% at September 30, 2022) quarterly principal payments of 0.25% of original principal balance with balloon payment due July 2028 $ 544,500 $ 548,625 Revolver with interest payable monthly, interest rate at Adjusted LIBOR or Alternative Base Rate, plus an applicable margin of 3.25% (6.37% at September 30, 2022), and outstanding balance due July 2026 — — Subordinated unsecured promissory note related to acquisition of Service Nation, Inc., interest paid-in-kind, interest rate at 8.5% with balloon payment due September 2022 — 2,866 Subordinated unsecured promissory note related to acquisition of Technique Fitness, Inc. D/B/A Club OS, interest paid-in-kind, interest rate at 7% with balloon payment due December 2022 2,797 2,655 Principal debt 547,297 554,146 Deferred financing costs on long-term debt (5,131) (5,826) Discount on long-term debt (1,878) (2,193) Total debt 540,288 546,127 Less current maturities 8,282 10,943 Long-term portion $ 532,006 $ 535,184
Schedule of Maturities of Long-term Debt	Aggregate maturities of the Company’s debt for the years ending December 31 are as follows as of September 30, 2022 (in thousands): Years ending December 31: 2022 (remaining three months) $ 4,211 2023 5,500 2024 5,500 2025 5,500 2026 5,500 Thereafter 521,125 Total aggregate maturities of the Company’s debt $ 547,336

Stock-Based Compensation (Table

Stock-Based Compensation (Tables)	9 Months Ended
	Sep. 30, 2022
Share-Based Payment Arrangement [Abstract]
Summary of Restricted Stock Unit and Stock Option Activity	The following table summarizes our restricted stock unit (“RSU”) and stock option activity for the nine months ended September 30, 2022: RSUs Options (in thousands) Outstanding as of January 1, 2022 541 16,444 Granted 1,521 1,480 Vested or exercised — (126) Cancelled or forfeited (10) (160) Outstanding as of March 31, 2022 2,052 17,638 Granted 211 146 Vested or exercised — (96) Cancelled or forfeited (163) (409) Outstanding as of June 30, 2022 2,100 17,279 Granted 95 54 Vested or exercised (116) (95) Cancelled or forfeited (56) (143) Outstanding as of September 30, 2022 2,023 17,095
Schedule of Stock-based Compensation Expense	Stock-based compensation expense was classified in the unaudited condensed consolidated statements of operations and comprehensive loss as follows: Three months ended Nine months ended 2022 2021 2022 2021 (in thousands) Cost of revenues $ 109 $ 173 $ 278 $ 178 Sales and marketing 380 160 1,127 298 Product development 501 295 1,389 437 General and administrative 6,143 4,117 16,982 15,936 Total stock-based compensation expense $ 7,133 $ 4,745 $ 19,776 $ 16,849

Net Loss Per Share Attributab_2

Net Loss Per Share Attributable to Common Stockholders (Tables)	9 Months Ended
	Sep. 30, 2022
Earnings Per Share [Abstract]
Schedule of Net Loss Per Share, Basic and Diluted	The following table presents the calculation of basic and diluted net loss per share for the Company’s common stock as of: Three months ended Nine months ended 2022 2021 2022 2021 (in thousands except share and per share amounts) Numerator: Net loss $ (15,853) $ (36,906) $ (42,043) $ (77,235) Accretion of Series B to redemption value — — — (15,105) Numerator for basic and diluted EPS – net loss attributable to common stockholders $ (15,853) $ (36,906) $ (42,043) $ (92,340) Denominator: Denominator for basic and diluted EPS – weighted-average shares of common stock outstanding used in computing net loss per share 194,542,764 187,994,437 195,205,260 91,655,461 Basic and diluted net loss per share attributable to common stockholders $ (0.08) $ (0.20) $ (0.22) $ (1.01)
Schedule of Antidilutive Outstanding Common Stock Excluded from Computation of Diluted Net Loss Per Share	The following outstanding potentially dilutive common stock equivalents have been excluded from the computation of diluted net loss per share attributable to common stockholders for the periods presented due to their anti-dilutive effect as of: September 30, 2022 2021 Outstanding options to purchase common stock and unvested RSUs 19,118,295 16,967,629 Total anti-dilutive outstanding potential common stock 19,118,295 16,967,629

Fair Value of Financial Instr_2

Fair Value of Financial Instruments (Tables)	9 Months Ended
	Sep. 30, 2022
Fair Value Disclosures [Abstract]
Schedule of Financial Assets and Liabilities at Fair Value on a Recurring Basis	The following table presents information about the Company's financial assets and liabilities measured at fair value on a recurring basis as of: September 30, 2022 Balance Sheet Classification Level 1 Level 2 Level 3 Total (in thousands) Asset: Money market $ 13,674 $ — $ — $ 13,674 Cash equivalents December 31, 2021 Balance Sheet Classification Level 1 Level 2 Level 3 Total (in thousands) Asset: Money market $ 14,855 $ — $ — $ 14,855 Cash equivalents Liability: Contingent consideration $ — $ — $ 675 $ 675 Other current liabilities
Schedule of Reconciliation of Opening and Closing Balances for Contingent Consideration	The following is a reconciliation of the opening and closing balance for contingent consideration measured at fair value on a recurring basis using significant unobservable inputs (Level 3) during the nine months ended September 30, 2022 (in thousands): Opening balance $ 675 Amounts settled through payment (657) Fair value adjustments (18) Ending balance $ —

Geographic Areas (Tables)

Geographic Areas (Tables)	9 Months Ended
	Sep. 30, 2022
Geographic Areas, Long-Lived Assets [Abstract]
Schedule of Long-Lived Assets by Geographic Areas	The following table sets forth long-lived assets by geographic area as of: September 30, December 31, 2022 2021 (in thousands) United States $ 36,015 $ 34,906 International $ 7,592 $ 2,603

Nature of the Business (Details

Nature of the Business (Details) customer in Thousands	Sep. 30, 2022 core_vertical customer
Organization, Consolidation and Presentation of Financial Statements [Abstract]
Number of customers | customer	600
Number of core verticals | core_vertical	3

Acquisitions - Narrative (Detai

Acquisitions - Narrative (Details) $ in Thousands					3 Months Ended		9 Months Ended	12 Months Ended
	Nov. 18, 2021 USD ($)	Jul. 08, 2021 USD ($)	Mar. 17, 2021 USD ($)	Jan. 19, 2021 USD ($) shares	Sep. 30, 2021 USD ($)	Jun. 30, 2021 USD ($)	Sep. 30, 2021 USD ($) business	Dec. 31, 2021 USD ($) business
Business Acquisition [Line Items]
Number of businesses acquired | business							4	5
Acquisition related costs					$ 4,100		$ 6,800	$ 8,400
Interest expense					4,900		11,700
Transaction costs removed					4,100		6,800
Additional amortization expense					$ 1,800		$ 8,400
Briostack
Business Acquisition [Line Items]
Percentage of interest acquired				100%
Purchase price				$ 35,200				35,167
Shares issued (in shares) | shares				45,454
Rollover equity						$ 700		726
PulseM
Business Acquisition [Line Items]
Percentage of interest acquired			100%
Purchase price			$ 34,400					34,430
Rollover equity								0
MDTech
Business Acquisition [Line Items]
Percentage of interest acquired		100%
Purchase price		$ 15,800						15,751
Rollover equity								0
Timely
Business Acquisition [Line Items]
Percentage of interest acquired		100%
Purchase price		$ 99,800						99,820
Rollover equity								0
DrChrono
Business Acquisition [Line Items]
Percentage of interest acquired	100%
Purchase price	$ 181,900							181,919
Rollover equity								$ 0

Acquisitions - Consideration Tr

Acquisitions - Consideration Transferred and Net Assets Acquired (Details) - USD ($) $ in Thousands					3 Months Ended	12 Months Ended
	Nov. 18, 2021	Jul. 08, 2021	Mar. 17, 2021	Jan. 19, 2021	Jun. 30, 2021	Dec. 31, 2021	Sep. 30, 2022
Net assets acquired:
Goodwill						$ 921,416	$ 907,243
Accrued expenses and other						(4,309)
Total net assets acquired						367,087
Developed technology
Net assets acquired:
Intangible						20,874
2021 Acquisitions
Business Acquisition [Line Items]
Cash						366,361
Rollover equity						726
Total consideration						367,087
Net assets acquired:
Cash and cash equivalents						1,417
Accounts receivable, trade						3,965
Other receivables						665
Contract Assets						1,172
Prepaid expenses and other current assets						3,362
Property and equipment						487
Deposits and other long-term assets						222
Goodwill						255,723
Deferred tax asset, net						3,400
Accounts payable						(3,169)
Other Current Liabilities						(2,784)
Deferred tax liability, net						(24,741)
Deferred revenue						(773)
2021 Acquisitions | Customer relationships
Net assets acquired:
Intangible						105,946
2021 Acquisitions | Trade name
Net assets acquired:
Intangible						5,514
2021 Acquisitions | Non-compete agreements
Net assets acquired:
Intangible						116
Briostack
Business Acquisition [Line Items]
Cash						34,441
Rollover equity					$ 700	726
Total consideration				$ 35,200		35,167
Net assets acquired:
Cash and cash equivalents						17
Accounts receivable, trade						156
Other receivables						222
Contract Assets						0
Prepaid expenses and other current assets						53
Property and equipment						22
Deposits and other long-term assets						144
Goodwill						28,274
Deferred tax asset, net						1
Accounts payable						(33)
Other Current Liabilities						(28)
Accrued expenses and other						(206)
Deferred tax liability, net						0
Deferred revenue						(28)
Total net assets acquired						35,167
Briostack | Developed technology
Net assets acquired:
Intangible						1,360
Briostack | Customer relationships
Net assets acquired:
Intangible						4,800
Briostack | Trade name
Net assets acquired:
Intangible						390
Briostack | Non-compete agreements
Net assets acquired:
Intangible						23
PulseM
Business Acquisition [Line Items]
Cash						34,430
Rollover equity						0
Total consideration			$ 34,400			34,430
Net assets acquired:
Cash and cash equivalents						0
Accounts receivable, trade						0
Other receivables						151
Contract Assets						0
Prepaid expenses and other current assets						32
Property and equipment						4
Deposits and other long-term assets						3
Goodwill						22,866
Deferred tax asset, net						0
Accounts payable						(113)
Other Current Liabilities						0
Accrued expenses and other						(99)
Deferred tax liability, net						(3,538)
Deferred revenue						(36)
Total net assets acquired						34,430
PulseM | Developed technology
Net assets acquired:
Intangible						2,380
PulseM | Customer relationships
Net assets acquired:
Intangible						12,510
PulseM | Trade name
Net assets acquired:
Intangible						260
PulseM | Non-compete agreements
Net assets acquired:
Intangible						10
MDTech
Business Acquisition [Line Items]
Cash						15,751
Rollover equity						0
Total consideration		$ 15,800				15,751
Net assets acquired:
Cash and cash equivalents						100
Accounts receivable, trade						175
Other receivables						48
Contract Assets						0
Prepaid expenses and other current assets						34
Property and equipment						16
Deposits and other long-term assets						0
Goodwill						7,899
Deferred tax asset, net						2
Accounts payable						(44)
Other Current Liabilities						0
Accrued expenses and other						(116)
Deferred tax liability, net						0
Deferred revenue						(43)
Total net assets acquired						15,751
MDTech | Developed technology
Net assets acquired:
Intangible						1,640
MDTech | Customer relationships
Net assets acquired:
Intangible						5,830
MDTech | Trade name
Net assets acquired:
Intangible						200
MDTech | Non-compete agreements
Net assets acquired:
Intangible						10
Timely
Business Acquisition [Line Items]
Cash						99,820
Rollover equity						0
Total consideration		$ 99,800				99,820
Net assets acquired:
Cash and cash equivalents						1,170
Accounts receivable, trade						290
Other receivables						95
Contract Assets						0
Prepaid expenses and other current assets						128
Property and equipment						219
Deposits and other long-term assets						52
Goodwill						69,737
Deferred tax asset, net						3,397
Accounts payable						(230)
Other Current Liabilities						(670)
Accrued expenses and other						(940)
Deferred tax liability, net						(10,463)
Deferred revenue						(292)
Total net assets acquired						99,820
Timely | Developed technology
Net assets acquired:
Intangible						7,014
Timely | Customer relationships
Net assets acquired:
Intangible						28,836
Timely | Trade name
Net assets acquired:
Intangible						1,414
Timely | Non-compete agreements
Net assets acquired:
Intangible						63
DrChrono
Business Acquisition [Line Items]
Cash						181,919
Rollover equity						0
Total consideration	$ 181,900					181,919
Net assets acquired:
Cash and cash equivalents						130
Accounts receivable, trade						3,344
Other receivables						149
Contract Assets						1,172
Prepaid expenses and other current assets						3,115
Property and equipment						226
Deposits and other long-term assets						23
Goodwill						126,947
Deferred tax asset, net						0
Accounts payable						(2,749)
Other Current Liabilities						(2,086)
Accrued expenses and other						(2,948)
Deferred tax liability, net						(10,740)
Deferred revenue						(374)
Total net assets acquired						181,919
DrChrono | Developed technology
Net assets acquired:
Intangible						8,480
DrChrono | Customer relationships
Net assets acquired:
Intangible						53,970
DrChrono | Trade name
Net assets acquired:
Intangible						3,250
DrChrono | Non-compete agreements
Net assets acquired:
Intangible						$ 10

Acquisitions - Pro Forma (Detai

Acquisitions - Pro Forma (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Business Combination and Asset Acquisition [Abstract]
Total revenue	$ 158,126	$ 140,362	$ 458,948	$ 395,273
Net loss	(15,853)	(40,775)	(42,043)	(94,003)
Adjustments to net loss per share (see Note 10)	0	0	0	(15,105)
Net loss attributable to common stockholders	$ (15,853)	$ (40,775)	$ (42,043)	$ (109,108)
Basic net loss per share attributable to common stockholders (in dollars per share)	$ (0.08)	$ (0.22)	$ (0.22)	$ (1.19)
Diluted net loss per share attributable to common stockholders (in dollars per share)	$ (0.08)	$ (0.22)	$ (0.22)	$ (1.19)

Revenue - Disaggregation of Rev

Revenue - Disaggregation of Revenue (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Disaggregation of Revenue [Line Items]
Total revenues	$ 158,126	$ 128,534	$ 458,948	$ 354,490
United States
Disaggregation of Revenue [Line Items]
Total revenues	146,492	118,721	418,510	325,179
International
Disaggregation of Revenue [Line Items]
Total revenues	11,634	9,813	40,438	29,311
Point in time
Disaggregation of Revenue [Line Items]
Total revenues	14,496	13,743	40,112	37,324
Over time
Disaggregation of Revenue [Line Items]
Total revenues	$ 143,630	$ 114,791	$ 418,836	$ 317,166

Revenue - Contract Balances (De

Revenue - Contract Balances (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Revenue from Contract with Customer [Abstract]
Accounts receivable, net	$ 49,762	$ 40,514
Contract assets	13,782	11,039
Deferred revenue	25,300	22,992
Customer deposits	10,176	9,828
Long-term deferred revenue	$ 2,596	$ 2,803

Revenue - Narrative (Details)

Revenue - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021
Capitalized Contract Cost [Line Items]
Revenue recognized			$ 20.9
Cost to obtain contracts amortization period	5 years		5 years
Short-term assets	$ 6.2		$ 6.2		$ 4.8
Long-term assets	14.3		14.3		$ 11.9
Sales and marketing expense
Capitalized Contract Cost [Line Items]
Amortization expense	1.1	$ 0.7	3.1	$ 2
Cost of revenues
Capitalized Contract Cost [Line Items]
Amortization expense	$ 0.4	$ 0.3	$ 1.2	$ 0.7

Revenue - Remaining Performance

Revenue - Remaining Performance Obligations (Details) $ in Millions	Sep. 30, 2022 USD ($)
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, amount	$ 22.3
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2022-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	59%
Remaining performance obligation, expected timing of satisfaction	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2023-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	27%
Remaining performance obligation, expected timing of satisfaction	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2024-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, percentage	10%
Remaining performance obligation, expected timing of satisfaction	1 year
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction, Start Date [Axis]: 2025-10-01
Revenue, Remaining Performance Obligation, Expected Timing of Satisfaction [Line Items]
Remaining performance obligation, expected timing of satisfaction	2 years

Goodwill (Details)

Goodwill (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Goodwill [Roll Forward]
Beginning balance	$ 921,416
Measurement period adjustments	(573)
Effect of foreign currency exchange rate changes	(13,600)
Ending balance	907,243	$ 921,416
2021 Acquisitions
Goodwill [Roll Forward]
Beginning balance	$ 255,723
Measurement period adjustments		(600)
Ending balance		$ 255,723

Intangible Assets - Summary (De

Intangible Assets - Summary (Details) - USD ($) $ in Thousands	9 Months Ended	12 Months Ended
	Sep. 30, 2022	Dec. 31, 2021
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 751,001	$ 754,414
Accumulated Amortization	320,768	245,879
Net Book Value	430,233	508,535
Customer relationships
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	604,914	607,625
Accumulated Amortization	245,509	187,556
Net Book Value	$ 359,405	$ 420,069
Customer relationships | Minimum
Finite-Lived Intangible Assets [Line Items]
Useful Life	3 years	3 years
Customer relationships | Maximum
Finite-Lived Intangible Assets [Line Items]
Useful Life	20 years	20 years
Developed technology
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 105,598	$ 106,162
Accumulated Amortization	54,893	42,215
Net Book Value	$ 50,705	$ 63,947
Developed technology | Minimum
Finite-Lived Intangible Assets [Line Items]
Useful Life	2 years	2 years
Developed technology | Maximum
Finite-Lived Intangible Assets [Line Items]
Useful Life	12 years	12 years
Trade name
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 38,095	$ 38,218
Accumulated Amortization	18,413	14,540
Net Book Value	$ 19,682	$ 23,678
Trade name | Minimum
Finite-Lived Intangible Assets [Line Items]
Useful Life	3 years	3 years
Trade name | Maximum
Finite-Lived Intangible Assets [Line Items]
Useful Life	10 years	10 years
Non-compete agreements
Finite-Lived Intangible Assets [Line Items]
Gross Carrying Value	$ 2,394	$ 2,409
Accumulated Amortization	1,953	1,568
Net Book Value	$ 441	$ 841
Non-compete agreements | Minimum
Finite-Lived Intangible Assets [Line Items]
Useful Life	2 years	2 years
Non-compete agreements | Maximum
Finite-Lived Intangible Assets [Line Items]
Useful Life	5 years	5 years

Intangible Assets - Narrative (

Intangible Assets - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Goodwill and Intangible Assets Disclosure [Abstract]
Amortization	$ 25.2	$ 24.2	$ 75.7	$ 68.7

Property and Equipment - Summar

Property and Equipment - Summary (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 25,406	$ 23,890
Less accumulated depreciation	(12,899)	(10,381)
Property and equipment, net	12,507	13,509
Computer equipment and software
Property, Plant and Equipment [Line Items]
Total property and equipment	9,918	8,191
Furniture and fixtures
Property, Plant and Equipment [Line Items]
Total property and equipment	3,560	3,667
Leasehold improvements
Property, Plant and Equipment [Line Items]
Total property and equipment	$ 11,928	$ 12,032

Property and Equipment - Narrat

Property and Equipment - Narrative (Details) - USD ($) $ in Millions	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Property, Plant and Equipment [Abstract]
Depreciation	$ 1	$ 1	$ 3.1	$ 2.8

Capitalized Software - Summary

Capitalized Software - Summary (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Research and Development [Abstract]
Capitalized software	$ 42,746	$ 31,960
Less: accumulated amortization	(11,646)	(7,960)
Capitalized software, net	$ 31,100	$ 24,000

Capitalized Software - Narrativ

Capitalized Software - Narrative (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Research and Development [Abstract]
Amortization	$ 1,400	$ 900	$ 3,700	$ 2,400
Capitalized software abandonment	$ 100		$ 580	$ 0

Long-Term Debt - Summary of Deb

Long-Term Debt - Summary of Debt (Details) - USD ($) $ in Thousands	9 Months Ended
	Sep. 30, 2022	Dec. 31, 2021	Nov. 30, 2021
Debt Instrument [Line Items]
Principal debt	$ 547,297	$ 554,146
Deferred financing costs on long-term debt	(5,131)	(5,826)
Discount on long-term debt	(1,878)	(2,193)
Total debt	540,288	546,127
Less current maturities	8,282	10,943
Long-term portion	532,006	535,184
New Term Loan | Term loan
Debt Instrument [Line Items]
Principal debt	$ 544,500	548,625
Effective interest rate	5.77%
Principal payment as a percentage of original principal balance	0.25%
New Term Loan | Base Rate Or London Interbank Offered Rate (LIBOR) | Term loan
Debt Instrument [Line Items]
Basis spread	3.25%
New Revolver | Revolving loans
Debt Instrument [Line Items]
Principal debt	$ 0	0
Total debt			$ 35,000
Effective interest rate	6.37%
New Revolver | Base Rate Or London Interbank Offered Rate (LIBOR) | Revolving loans
Debt Instrument [Line Items]
Basis spread	3.25%
Subordinated Unsecured Promissory Note, Service Nation, Inc | Subordinated unsecured promissory note
Debt Instrument [Line Items]
Principal debt	$ 0	2,866
Interest rate	8.50%
Subordinated Unsecured Promissory Note, Technique Fitness, Inc | Subordinated unsecured promissory note
Debt Instrument [Line Items]
Principal debt	$ 2,797	$ 2,655
Interest rate	7%

Long-Term Debt - Narrative (Det

Long-Term Debt - Narrative (Details) - USD ($)	1 Months Ended	3 Months Ended		9 Months Ended
	Nov. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021	Dec. 31, 2021	Jul. 06, 2021
Debt Instrument [Line Items]
Loss on debt extinguishment		$ 0	$ (28,714,000)	$ 0	$ (28,714,000)
Amount outstanding		540,288,000		540,288,000		$ 546,127,000
Debt repaid				6,125,000	837,082,000
Paid-in-kind interest on long-term debt		100,000	$ 100,000	300,000	$ 300,000
Level 2 | Fair Value
Debt Instrument [Line Items]
Fair value		520,100,000		$ 520,100,000		$ 552,800,000
New Term Loan | Term loan
Debt Instrument [Line Items]
Maximum borrowing capacity							$ 350,000,000
Increase in borrowing capacity	$ 200,000,000
New Revolver | Revolving loans
Debt Instrument [Line Items]
Maximum borrowing capacity							190,000,000
Amount outstanding	35,000,000
Debt repaid	$ 190,000,000
New Revolver | Letter of credit
Debt Instrument [Line Items]
Maximum borrowing capacity							$ 20,000,000
Legacy Subordinated Notes | Subordinated Debt
Debt Instrument [Line Items]
Debt repaid		2,000,000
Paid-in-kind interest on long-term debt		$ 1,000,000

Long-Term Debt - Maturities (De

Long-Term Debt - Maturities (Details) $ in Thousands	Sep. 30, 2022 USD ($)
Debt Disclosure [Abstract]
2022 (remaining three months)	$ 4,211
2023	5,500
2024	5,500
2025	5,500
2026	5,500
Thereafter	521,125
Total debt	$ 547,336

Equity (Details)

Equity (Details) $ / shares in Units, $ in Thousands	1 Months Ended	3 Months Ended				9 Months Ended
	May 31, 2021 USD ($) shares	Sep. 30, 2022 USD ($) $ / shares shares	Jun. 30, 2022 USD ($)	Jun. 30, 2021 shares	Mar. 31, 2021 USD ($)	Sep. 30, 2022 USD ($) $ / shares shares	Sep. 30, 2021 USD ($)	Nov. 07, 2022 USD ($)	Jun. 14, 2022 USD ($)	Dec. 31, 2021 $ / shares shares	Jul. 06, 2021 $ / shares shares	May 05, 2021 $ / shares shares	May 04, 2021 shares
Class of Stock [Line Items]
Convertible preferred stock, shares authorized (in shares)												140,000,000	125,000,000
Convertible preferred stock, par value (in dollars per share) | $ / shares												$ 0.00001
Proceeds from issuance of convertible preferred stock | $						$ 0	$ 109,782
Accretion of Series B convertible preferred stock to redemption value | $					$ 15,105
Shares authorized (in shares)											2,050,000,000
Common stock, par value (in dollars per share) | $ / shares		$ 0.00001				$ 0.00001				$ 0.00001	$ 0.00001
Preferred stock, par value (in dollars per share) | $ / shares		$ 0.00001				$ 0.00001				$ 0.00001	$ 0.00001
Common stock, shares authorized (in shares)		2,000,000,000				2,000,000,000				2,000,000,000	2,000,000,000
Preferred stock, shares authorized (in shares)		50,000,000				50,000,000				50,000,000	50,000,000
Convertible preferred stock ratio											1
Repurchase and retirement of common shares (in shares)		1,801,062				2,097,108
Repurchase and retirement of common stock | $		$ 19,198	$ 2,665			$ 21,900
Subsequent Event
Class of Stock [Line Items]
Stock repurchase program with authorization | $								$ 100,000
Maximum
Class of Stock [Line Items]
Stock repurchase program with authorization | $									$ 50,000
Maximum | Subsequent Event
Class of Stock [Line Items]
Repurchase program, additional authorized amount | $								$ 50,000
Series A Convertible Preferred Stock
Class of Stock [Line Items]
Convertible preferred stock, shares authorized (in shares)												50,000,000
Series B Convertible Preferred Stock
Class of Stock [Line Items]
Convertible preferred stock, shares authorized (in shares)												75,000,000
Accretion of Series B convertible preferred stock to redemption value | $							$ 15,100
Series C Convertible Preferred Stock
Class of Stock [Line Items]
Convertible preferred stock, shares authorized (in shares)												15,000,000
Issuance of convertible preferred stock, net (in shares)	7,900,000			7,857,000
Proceeds from issuance of convertible preferred stock | $	$ 109,800

Stock-Based Compensation - Narr

Stock-Based Compensation - Narrative (Details) - USD ($) $ in Millions	Jan. 01, 2022	Jul. 06, 2021	Sep. 30, 2022
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Unrecognized compensation expense, RSUs			$ 22.2
Unrecognized compensation expense, stock options			$ 28.7
2021 Incentive Award Plan
Share-based Compensation Arrangement by Share-based Payment Award [Line Items]
Shares reserved for issuance (in shares)		22,000,000
Percentage of stock outstanding		3%
Additional shares reserved for issuance (in shares)	5,900,000

Stock-Based Compensation - RSU

Stock-Based Compensation - RSU and Stock Option Activity (Details) - shares shares in Thousands	3 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022
Options
Beginning balance (in shares)	17,279	17,638	16,444
Granted (in shares)	54	146	1,480
Vested or exercised (in shares)	(95)	(96)	(126)
Cancelled or forfeited (in shares)	(143)	(409)	(160)
Ending balance (in shares)	17,095	17,279	17,638
RSUs
RSUs
Beginning balance (in shares)	2,100	2,052	541
Granted (in shares)	95	211	1,521
Vested or exercised (in shares)	(116)	0	0
Cancelled or forfeited (in shares)	(56)	(163)	(10)
Ending balance (in shares)	2,023	2,100	2,052

Stock-Based Compensation - Stoc

Stock-Based Compensation - Stock-based Compensation Expense (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 7,133	$ 4,745	$ 19,776	$ 16,849
Cost of revenues
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	109	173	278	178
Sales and marketing
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	380	160	1,127	298
Product development
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	501	295	1,389	437
General and administrative
Share-based Payment Arrangement, Expensed and Capitalized, Amount [Line Items]
Stock-based compensation expense	$ 6,143	$ 4,117	$ 16,982	$ 15,936

Net Loss Per Share Attributab_3

Net Loss Per Share Attributable to Common Stockholders - Schedule of Net Loss Per Share (Details) - USD ($) $ / shares in Units, $ in Thousands	3 Months Ended						9 Months Ended
	Sep. 30, 2022	Jun. 30, 2022	Mar. 31, 2022	Sep. 30, 2021	Jun. 30, 2021	Mar. 31, 2021	Sep. 30, 2022	Sep. 30, 2021
Numerator:
Net loss	$ (15,853)	$ (12,881)	$ (13,309)	$ (36,906)	$ (24,334)	$ (15,995)	$ (42,043)	$ (77,235)
Accretion of Series B to redemption value	0			0			0	(15,105)
Net loss attributable to common stockholders, basic	(15,853)			(36,906)			(42,043)	(92,340)
Net loss attributable to common stockholders, diluted	$ (15,853)			$ (36,906)			$ (42,043)	$ (92,340)
Denominator:
Denominator for basic EPS - weighted-average shares of common stock outstanding used in computing net loss per share (in shares)	194,542,764			187,994,437			195,205,260	91,655,461
Denominator for diluted EPS - weighted-average shares of common stock outstanding used in computing net loss per share (in shares)	194,542,764			187,994,437			195,205,260	91,655,461
Basic net loss per share attributable to common stockholders (in dollars per share)	$ (0.08)			$ (0.20)			$ (0.22)	$ (1.01)
Diluted net loss per share attributable to common stockholders (in dollars per share)	$ (0.08)			$ (0.20)			$ (0.22)	$ (1.01)

Net Loss Per Share Attributab_4

Net Loss Per Share Attributable to Common Stockholders - Antidilutive Common Stock Excluded from Computation of Diluted Net Loss Per Share (Details) - shares	9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive outstanding potential common stock	19,118,295	16,967,629
Outstanding options to purchase common stock and unvested RSUs
Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items]
Total anti-dilutive outstanding potential common stock	19,118,295	16,967,629

Fair Value of Financial Instr_3

Fair Value of Financial Instruments - Financial Assets and Liabilities at Fair Value On a Recurring Basis (Details) - Fair Value, Recurring - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
Liability
Contingent consideration		$ 675
Level 1
Liability
Contingent consideration		0
Level 2
Liability
Contingent consideration		0
Level 3
Liability
Contingent consideration		675
Money market
Asset
Money market	$ 13,674	14,855
Money market | Level 1
Asset
Money market	13,674	14,855
Money market | Level 2
Asset
Money market	0	0
Money market | Level 3
Asset
Money market	$ 0	$ 0

Fair Value of Financial Instr_4

Fair Value of Financial Instruments - Schedule of Reconciliation of Contingent Consideration Measured at Fair Value (Details) - Level 3 - Fair Value, Recurring $ in Thousands	9 Months Ended
	Sep. 30, 2022 USD ($)
Fair Value, Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation, Calculation [Roll Forward]
Opening balance	$ 675
Amounts settled through payment	(657)
Fair value adjustments	(18)
Ending balance	$ 0

Income Taxes (Details)

Income Taxes (Details) - USD ($) $ in Thousands	3 Months Ended		9 Months Ended
	Sep. 30, 2022	Sep. 30, 2021	Sep. 30, 2022	Sep. 30, 2021
Income Tax Disclosure [Abstract]
Income tax benefit	$ 291	$ 1,022	$ 5,953	$ 4,182
Effective income tax rate	1.80%	2.70%	12.40%	5.10%

Geographic Areas (Details)

Geographic Areas (Details) - USD ($) $ in Thousands	Sep. 30, 2022	Dec. 31, 2021
United States
Finite-Lived Intangible Assets [Line Items]
Long-lived assets	$ 36,015	$ 34,906
International
Finite-Lived Intangible Assets [Line Items]
Long-lived assets	$ 7,592	$ 2,603

Subsequent Events (Details)

Subsequent Events (Details) - Subsequent Event - Interest rate swap	Oct. 31, 2022 USD ($)
Subsequent Event [Line Items]
Notional amount	$ 200,000,000
Agreement term	5 years
Fixed interest rate	4.2295%